Evidence map›Paper›PMID 38111549›Full record

ArticleRadiology case reports2024

SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report.

Akira Kambe, Yayoi Yamamoto, Chie Hasegawa, Akira Kakiuchi, Daichi Kojima, Ayako Hino, Ayumi Horikawa, Tsunehiro Doiuchi, Hiroaki Kurihara

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. ThoracicRadiology case reports · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akira KambeDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Yayoi YamamotoDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Chie HasegawaDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Akira KakiuchiDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Daichi KojimaDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Ayako HinoDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Ayumi HorikawaDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Tsunehiro DoiuchiDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Hiroaki KuriharaDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UTs) are rare undifferentiated thoracic malignancies with poor prognosis. They predominantly affect young men who are heavy smokers. Recently, the category of SMARCA4-deficiency-related malignancy has been expanded to include extra-thoracic sites, such as the paranasal sinuses, gastrointestinal tract, ovary, and uterus. We report a rare case of SMARCA4-deficient tumors in the adrenal gland and small intestines. SMARCA4-deficient tumors should be included in the differential diagnosis when multiple large masses with heterogeneous contrast effect and strong accumulation are seen in cancers of unknown primary on 18F-fluorodeoxyglucose (FDG) positron emission tomography with computed tomography (PET/CT).

Indexed as

Cancers of unknown primarySMARCA4-deficient tumorSMARCA4-deficient undifferentiated tumor

Identifiers

PMID38111549
PMCPMC10726321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.